View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
 PRESS RELEASE

FLSmidth & Co. A/S financial calendar for 2026

FLSmidth & Co. A/S financial calendar for 2026 COMPANY ANNOUNCEMENT NO. 43-2025 FLSmidth & Co. A/S 12 November 2025 Copenhagen, Denmark For the year 2026, FLSmidth has planned the following dates for the release of financial reports and the annual general meeting: 18 February 2026: 2025 Annual Report24 March 2026: Annual General Meeting13 May 2026: Q1 2026 Interim Financial Report19 August 2026: H1 2026 Interim Financial Report11 November 2026: Q3 2026 Interim Financial Report Contacts: Investor RelationsAndreas Holkjær, , Jannick Denholt, , MediaJannick Denholt, , About FLSmi...

 PRESS RELEASE

FLSmidth: Transactions under share buy-back programme

FLSmidth: Transactions under share buy-back programme COMPANY ANNOUNCEMENT NO. 42-2025 FLSmidth & Co. A/S 12 November 2025 Copenhagen, Denmark On 25 June 2025, FLSmidth & Co. A/S (FLSmidth) initiated a share buy-back programme of up to DKK 1.4 billion (ref. Company Announcement no. 12-2025). Under the share buy-back programme, FLSmidth may repurchase shares up to a maximum amount of DKK 1.4 billion, and no more than 4,600,000 shares, corresponding to approximately 8 percent of the share capital of the company. The share buy-back programme will be executed in accordance with Article 5 of...

 PRESS RELEASE

FLSmidth & Co. A/S Q3 2025 Interim Financial Report: 10% organic Servi...

FLSmidth & Co. A/S Q3 2025 Interim Financial Report: 10% organic Service order growth in Q3 2025 and solid year-to-date PC&V performance; full-year revenue guidance adjusted COMPANY ANNOUNCEMENT NO. 41-2025FLSmidth & Co. A/S 12 November 2025 Copenhagen, Denmark Today, the Board of Directors of FLSmidth have approved the Q3 2025 Interim Financial Report. Highlights in Q3 2025: Service orders increased by 10% organically in Q3 2025, affirming the positive market momentumWhile engineering and planning activity continued at high levels in the quarter, the timing of project sanctioning rem...

 PRESS RELEASE

Coloplast A/S - Indkaldelse til ordinær generalforsamling 2025

Coloplast A/S - Indkaldelse til ordinær generalforsamling 2025 Indkaldelse til ordinær generalforsamling 2025 Den ordinære generalforsamling i Coloplast A/S afholdes torsdag den 4. december 2025 kl. 15:30 på Coloplast A/S’ adresse, Holtedam 3 (Aage Louis-Hansen Auditorium), Humlebæk, Danmark. Indkaldelsen til den ordinære generalforsamling er vedlagt.     For yderligere information, kontakt venligst Investorer og analytikereAnders Lonning-SkovgaardExecutive Vice President, CFOTlf. 4911 1111 Kristine Husted MunkSr. Director, Investor RelationsTlf. 4911 1800 / 4911 3266Email: Simo...

 PRESS RELEASE

Coloplast A/S - Notice of Annual General Meeting 2025

Coloplast A/S - Notice of Annual General Meeting 2025 Notice of Annual General Meeting 2025 The Annual General Meeting of Coloplast A/S will be held on Thursday, 4 December 2025 at 3:30 pm CET at the premises of Coloplast A/S, Holtedam 3 in Humlebæk (the Aage Louis-Hansen Auditorium), Humlebæk, Denmark. The notice of the Annual General Meeting is enclosed.   For further information, please contact Investors and analystsAnders Lonning-SkovgaardExecutive Vice President, CFOTel. Kristine Husted MunkSr. Director, Investor RelationsTel. / Email: Simone Dyrby HelvindSr. Manager, Inve...

 PRESS RELEASE

FLSmidth announces changes among employee-elected board members

FLSmidth announces changes among employee-elected board members COMPANY ANNOUNCEMENT NO. 40-2025 FLSmidth & Co. A/S 10 November 2025 Copenhagen, Denmark As a result of organisational changes, whereby the AI & Data Science Centre of Excellence has been closed, Henrik Stender Christensen, Solution Architect, RPA, will be leaving the company and will therefore be stepping down from his role as employee-elected board member in FLSmidth & Co. A/S (FLSmidth). The first alternate, Henrik Jørgensen, Lead Facility Management Specialist, replaces Henrik Stender Christensen on the Board of Director...

 PRESS RELEASE

FLSmidth: Transactions under share buy-back programme

FLSmidth: Transactions under share buy-back programme COMPANY ANNOUNCEMENT NO. 39-2025 FLSmidth & Co. A/S 5 November 2025 Copenhagen, Denmark On 25 June 2025, FLSmidth & Co. A/S (FLSmidth) initiated a share buy-back programme of up to DKK 1.4 billion (ref. Company Announcement no. 12-2025). Under the share buy-back programme, FLSmidth may repurchase shares up to a maximum amount of DKK 1.4 billion, and no more than 4,600,000 shares, corresponding to approximately 8 percent of the share capital of the company. The share buy-back programme will be executed in accordance with Article 5 of ...

ABGSC Healthcare Research ... (+2)
  • ABGSC Healthcare Research
  • Morten Larsen
ABGSC Healthcare Research ... (+2)
  • ABGSC Healthcare Research
  • Morten Larsen
 PRESS RELEASE

Coloplast A/S - Annual Report 2024/25 & Remuneration Report 2024/25

Coloplast A/S - Annual Report 2024/25 & Remuneration Report 2024/25 Coloplast A/S - Annual Report 2024/25 & Remuneration Report 2024/25 FY 2024/25 organic growth of 7% and EBIT margin1 of 28%. Reported revenue in DKK grew 3% to DKK 27,874 million.• Organic growth rates by business area: Ostomy Care 6%, Continence Care 8%, Voice & Respiratory Care 9%, Wound & Tissue Repair 8% and Interventional Urology 2%.• EBIT1,2 was DKK 7,670 million, a 5% increase from last year. The EBIT margin1,2 was 28%, against 27% last year.• Adjusted3 net profit before special items was DKK 5,148 million, a DKK 12...

 PRESS RELEASE

Coloplast A/S - Årsregnskabsmeddelelse 2024/25

Coloplast A/S - Årsregnskabsmeddelelse 2024/25 2024/25Årsregnskabsmeddelelse 1. oktober 2024 - 30. september 2025 Organisk vækst på 7% og en overskudsgrad1 på 28% i 4. kvartal. Den rapporterede omsætning i danske kroner steg 0%, negativt påvirket af valutaudviklingen samt frasalget af hudplejeforretningen.• Organisk vækst pr. område: Stomi 7%, Kontinens 9%, Stemme og Respiratorisk Pleje 9%, Wound & Tissue Repair 5% og Urologi 2%.• Væksten i Stomi var bredt funderet, med et godt bidrag fra nylige produktlanceringer og drevet af Europa og Øvrige markeder ex. Kina. Salget i Kina fa...

 PRESS RELEASE

Coloplast A/S - Full-Year Financial Results 2024/25

Coloplast A/S - Full-Year Financial Results 2024/25 2024/25Full year financial results 1 October 2024 - 30 September 2025 Coloplast delivered Q4 organic growth of 7% and an EBIT margin1 of 28%. Reported revenue in DKK grew 0% with negative impact from currencies and the Skin Care divestment.• Organic growth rates by business area: Ostomy Care 7%, Continence Care 9%, Voice & Respiratory Care 9%, Wound & Tissue Repair 5% and Interventional Urology 2%.• Growth in Ostomy Care was broad based with good contribution from recent product launches and led by Europe and Emerging Markets ex. China. ...

 PRESS RELEASE

FLSmidth & Co. A/S major shareholder announcement

FLSmidth & Co. A/S major shareholder announcement COMPANY ANNOUNCEMENT NO. 38-2025 FLSmidth & Co. A/S 31 October 2025 Copenhagen, Denmark FLSmidth & Co. A/S (“FLSmidth” or the “Company”) hereby announces the following notification received pursuant to section 39 of the Danish Capital Markets Act from Société Générale S.A. regarding its holdings of financial instruments relating to shares in FLSmidth. On 30 October 2025, Société Générale S.A. informed FLSmidth that, as of 27 October 2025, its aggregate holding of financial instruments with a similar economic effect to holding shares in FL...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch